Cargando…
Newer Treatment Modalities in Epidermolysis Bullosa
The term epidermolysis bullosa (EB) refers to a group of hereditary skin blistering diseases. The group is clinically and genetically heterogeneous, but all EB forms are associated with mechanically induced skin blistering and fragility. The causative gene mutations of most EB types are known. The c...
Autor principal: | Bruckner-Tuderman, Leena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536064/ https://www.ncbi.nlm.nih.gov/pubmed/31149565 http://dx.doi.org/10.4103/idoj.IDOJ_287_18 |
Ejemplares similares
-
The Epidermolysis bullosa Center Freiburg – patient care, diagnostics and research
por: Bruckner-Tuderman, Leena, et al.
Publicado: (2014) -
Dystrophic Epidermolysis Bullosa: Secondary Disease Mechanisms and Disease Modifiers
por: Nyström, Alexander, et al.
Publicado: (2021) -
Mapping health care of rare diseases: the example of epidermolysis bullosa in Germany
por: Reimer, Antonia, et al.
Publicado: (2018) -
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
por: Nyström, Alexander, et al.
Publicado: (2015) -
Progress Towards Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015
por: Uitto, Jouni, et al.
Publicado: (2016)